Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
Open accessAbstract
TEA domain (TEAD) transcription factors bind to the coactivators YAP and TAZ and regulate the transcriptional output of the Hippo pathway, playing critical roles in organ size control and tumorigenesis. Protein S-palmitoylation attaches a fatty acid, palmitate, to cysteine residues and regulates protein trafficking, membrane localization and signaling activities. Using activity-based chemical probes, we discovered that human TEADs possess intrinsic palmitoylating enzyme-like activities and undergo autopalmitoylation at evolutionarily conserved cysteine residues under physiological conditions. We determined the crystal structures of lipid-bound TEADs and found that the lipid chain of palmitate inserts into a conserved deep hydrophobic pocket. Strikingly, palmitoylation did not alter TEAD's localization, but it was required for TEAD's binding to YAP and TAZ and was dispensable for its binding to the Vgll4 tumor suppressor. Moreover, palmitoylation-deficient TEAD mutants impaired TAZ-mediated muscle differentiation in vitro and tissue overgrowth mediated by the Drosophila YAP homolog Yorkie in vivo. Our study directly links autopalmitoylation to the transcriptional regulation of the Hippo pathway.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
YAP/TAZ primarily pairs with the TEAD family of TFs to induce gene expression signatures that play an important role in cancer development, progression, and metastasis.
“YAP/TAZ primarily pairs with the TEAD family of TFs to induce gene expression signatures that play an important role in cancer development, progression, and metastasis.435,436”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [436]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · see citing works
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · see citing works
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · see citing works
Self-citationThe Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works
Self-citationThe Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3458 · Cited by 1,852 · see citing works
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452 · see citing works
Self-citationThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R. L., & Halder, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 884 · see citing works
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase
Nagar, B., Hantschel, O. D., Young, M. A., Scheffzek, K., Veach, D. R., Bornmann, W. G., Clarkson, B., Superti‐Furga, G., & Kuriyan, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00194-6 · Cited by 880 · see citing works
Metabolic control of YAP and TAZ by the mevalonate pathway
Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Ingallina, E., Sommaggio, R., Piazza, S., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2936 · Cited by 776 · see citing works
Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling
Færgeman, N. J., & Knudsen, J. (1997) · Biochemical Journal · doi:10.1042/bj3230001 · Cited by 681 · see citing works
Hippo signaling in organ size controlPreprint
Pan, D. (2007) · Genes & Development · doi:10.1101/gad.1536007 · Cited by 648 · see citing works
Self-citationWu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640 · see citing works
Self-citationProtein palmitoylation in neuronal development and synaptic plasticity
Fukata, Y., & Fukata, M. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2788 · Cited by 614 · see citing works
Palmitoylation of Intracellular Signaling Proteins: Regulation and Function
Smotrys, J. E., & Linder, M. E. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073954 · Cited by 611 · see citing works
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 605 · see citing works
Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
Zimmermann, G., Papke, B., Ismail, S., Vartak, N., Chandra, A., Hoffmann, M., Hahn, S. A., Triola, G., Wittinghofer, A., Bastiaens, P. I. H., et al. (2013) · Nature · doi:10.1038/nature12205 · Cited by 596 · see citing works
Global Analysis of Protein Palmitoylation in Yeast
Roth, A. F., Wan, J., Bailey, A. O., Sun, B., Kuchar, J. A., Green, W. N., Phinney, B. S., Yates, J. R., & Davis, N. G. (2006) · Cell · doi:10.1016/j.cell.2006.03.042 · Cited by 540 · see citing works
Trafficking and signaling by fatty-acylated and prenylated proteins
Resh, M. D. (2006) · Nature Chemical Biology · doi:10.1038/nchembio834 · Cited by 521 · see citing works
Large-scale profiling of protein palmitoylation in mammalian cells
Martin, B. R., & Cravatt, B. F. (2009) · Nature Methods · doi:10.1038/nmeth.1293 · Cited by 511 · see citing works
A Myristoyl/Phosphotyrosine Switch Regulates c-Abl
Hantschel, O. D., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., & Superti‐Furga, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00191-0 · Cited by 482 · see citing works
Palmitoylated proteins: purification and identification
Wan, J., Roth, A. F., Bailey, A. O., & Davis, N. G. (2007) · Nature Protocols · doi:10.1038/nprot.2007.225 · Cited by 417 · see citing works
Structural insights into the YAP and TEAD complexPreprint
Li, Z., Zhao, B., Wang, P., Chen, F., Dong, Z., Yang, H., Guan, K., & Xu, Y. (2010) · Genes & Development · doi:10.1101/gad.1865810 · Cited by 406 · see citing works
Ota, M., & Sasaki, H. (2008) · Development · doi:10.1242/dev.027151 · Cited by 391 · see citing works
Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3
Yount, J. S., Moltedo, B., Yang, Y.-Y., Charron, G., Moran, T. M., López, C. B., & Hang, H. C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.405 · Cited by 367 · see citing works
DHHC palmitoyl transferases: substrate interactions and (patho)physiology
Greaves, J., & Chamberlain, L. H. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.01.003 · Cited by 336 · see citing works
Chandra, A., Grecco, H. E., Pisupati, V., Perera, D., Cassidy, L., Skoulidis, F., Ismail, S. A., Hedberg, C., Hanzal-Bayer, M., Venkitaraman, A. R., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2394 · Cited by 325 · see citing works
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.10 · Cited by 300 · see citing works
Self-citationKoontz, L. M., Liu‐Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., Chen, Q., Wu, S., & Pan, D. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.04.021 · Cited by 282 · see citing works
Self-citationNoland, C. L., Gierke, S., Schnier, P. D., Murray, J. M., Sandoval, W. N., Sagolla, M. S., Dey, A., Hannoush, R. N., Fairbrother, W. J., & Cunningham, C. N. (2015) · Structure · doi:10.1016/j.str.2015.11.005 · Cited by 268 · see citing works
Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo
Ismail, S. A., Chen, Y.-X., Rusinova, A., Chandra, A., Bierbaum, M., Gremer, L., Triola, G., Waldmann, H., Bastiaens, P. I. H., & Wittinghofer, A. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.686 · Cited by 252 · see citing works
Structural basis of YAP recognition by TEAD4 in the Hippo pathwayPreprint
Chen, L., Chan, S. W., Zhang, X., Walsh, M. A., Lim, C. J., Hong, W., & Song, H. (2010) · Genes & Development · doi:10.1101/gad.1865310 · Cited by 251 · see citing works
Jennings, B. C., & Linder, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337246 · Cited by 220 · see citing works
Pobbati, A. V., Han, X. Y., Hung, A. W., Seetoh, W.-G., Huda, N., Chen, G.-Y., Kang, C., Chia, C. S. B., Luo, X., Hong, W., et al. (2015) · Structure · doi:10.1016/j.str.2015.09.009 · Cited by 212 · see citing works
Self-citationAutoacylation of G Protein α Subunits
Duncan, J. A., & Gilman, A. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23594 · Cited by 195 · see citing works
Structural and functional analysis of the YAP-binding domain of human TEAD2
Tian, W., Yu, J., Tomchick, D. R., Pan, D., & Luo, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000293107 · Cited by 171 · see citing works
Self-citationUse of analogs and inhibitors to study the functional significance of protein palmitoylation
Resh, M. D. (2006) · Methods · doi:10.1016/j.ymeth.2006.04.013 · Cited by 157 · see citing works
Zhou, Z., Hu, T., Xu, Z., Lin, Z., Zhang, Z., Feng, T., Zhu, L., Rong, Y., Shen, H. C., Luk, J. M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-262980 · Cited by 144 · see citing works
Photoreceptor cGMP Phosphodiesterase δ Subunit (PDEδ) Functions as a Prenyl-binding Protein
Zhang, H., Liu, X., Zhang, K., Chen, C.-K., Frederick, J. M., Prestwich, G. D., & Baehr, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306559200 · Cited by 126 · see citing works
Exploring Protein Lipidation with Chemical Biology
Hang, H. C., & Linder, M. E. (2011) · Chemical Reviews · doi:10.1021/cr2001977 · Cited by 114 · see citing works
2-Bromopalmitate Analogues as Activity-Based Probes To Explore Palmitoyl Acyltransferases
Zheng, B., DeRan, M., Li, X., Liao, X., Fukata, M., & Wu, X. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311416v · Cited by 96 · see citing works
Self-citationBenhaddou, A., Keime, C., Ye, T., Morlon, A., Michel, I., Jost, B., Mengus, G., & Davidson, I. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.87 · Cited by 93 · see citing works
Yang, Z., Nakagawa, K., Sarkar, A., Maruyama, J., Iwasa, H., Bao, Y., Ishigami‐Yuasa, M., Ito, S., Kagechika, H., Hata, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01346-13 · Cited by 58 · see citing works
Structure of palmitoylated BET3: insights into TRAPP complex assembly and membrane localization
Turnbull, A. P., Kümmel, D., Prinz, B., Holz, C., Schultchen, J., Lang, C., Niesen, F., Hofmann, K., Delbrück, H., Behlke, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600565 · Cited by 58 · see citing works
Kümmel, D., Heinemann, U., & Veit, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603513103 · Cited by 48 · see citing works
Yang, J., Gibson, B., Snider, J., Jenkins, C. M., Han, X., & Gross, R. W. (2005) · Biochemistry · doi:10.1021/bi0508082 · Cited by 44 · see citing works
Self-citationClickable Analogue of Cerulenin as Chemical Probe to Explore Protein Palmitoylation
Zheng, B., Zhu, S., & Wu, X. (2014) · ACS Chemical Biology · doi:10.1021/cb500758s · Cited by 40 · see citing works
Self-citationNovel TAZ modulators enhance myogenic differentiation and muscle regeneration
Park, G. H., Jeong, H., Jeong, M. G., Jang, E. J., Bae, M. A., Lee, Y., Kim, N. J., Hong, J., & Hwang, E. S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12755 · Cited by 27 · see citing works
Profiling Cellular Myristoylation and Palmitoylation Using ω-Alkynyl Fatty Acids
Hannoush, R. N. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-349-3_7 · Cited by 21 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [47]Wan J Roth AF Bailey AO Davis NG Palmitoylated proteins: purification and identification Nature protocols 2007 2 1573 1584 17585299
- [48]Fukata Y Fukata M Protein palmitoylation in neuronal development and synaptic plasticity Nature reviews. Neuroscience 2010 11 161 175 20168314
Cited by
Sorted by citations
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867 · see citing works
Self-citationTargeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860 · see citing works
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 767 · see citing works
The role of lipids in cancer progression and metastasis
Martín‐Pérez, M., Urdiroz-Urricelqui, U., Bigas, C., & Benitah, S. A. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.023 · Cited by 577 · see citing works
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
Jiang, H., Zhang, X., Chen, X., Aramsangtienchai, P., Tong, Z., & Lin, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00750 · Cited by 501 · see citing works
YAP/TAZ Signaling and Resistance to Cancer Therapy
Nguyen, C. D. K., & Yi, C. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.010 · Cited by 437 · see citing works
Kurppa, K. J., Liu, Y., To, C., Zhang, T., Fan, M., Vajdi, A., Knelson, E. H., Xie, Y., Lim, K., Cejas, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.006 · Cited by 475 · see citing works
Interplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 468 · see citing works
Protein palmitoylation and cancer
Ko, P., & Dixon, S. J. (2018) · EMBO Reports · doi:10.15252/embr.201846666 · Cited by 429 · see citing works
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Calses, P. C., Crawford, J. J., Lill, J. R., & Dey, A. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.04.001 · Cited by 423 · see citing works
Advances in Targeting ‘Undruggable’ transcription Factors With Small Molecules
Henley, M. J., & Koehler, A. N. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00199-0 · Cited by 409 · see citing works
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works
Regulation of the Hippo Pathway Transcription Factor TEAD
Lin, K. C., Park, H. W., & Guan, K. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.09.003 · Cited by 334 · see citing works
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 334 · see citing works
Fatty acylation of proteins: The long and the short of it
Resh, M. D. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.05.002 · Cited by 277 · see citing works
Chen, B., Sun, Y., Niu, J., Jarugumilli, G. K., & Wu, X. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.05.003 · Cited by 274 · see citing works
Self-citationFluorescent probes for the detection of disease-associated biomarkers
Dou, W., Han, H., Sedgwick, A. C., Zhu, G.-B., Zang, Y., Yang, X., Yoon, J., James, T. D., Li, J. X., & He, X. (2022) · 中国科学通报：英文版 · doi:10.1016/j.scib.2022.01.014 · Cited by 267 · see citing works
Tang, T. T., Konradi, A. W., Feng, Y., Peng, X., Ma, M., Li, J., Yu, F.-X., Guan, K.-L., & Post, L. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0717 · Cited by 245 · see citing works
Regulation of TEAD Transcription Factors in Cancer Biology
Huh, H., Kim, D., Jeong, H.-S., & Park, H. (2019) · Cells · doi:10.3390/cells8060600 · Cited by 259 · see citing works
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
Piccolo, S., Panciera, T., Contessotto, P., & Cordenonsi, M. (2022) · Nature Cancer · doi:10.1038/s43018-022-00473-z · Cited by 250 · see citing works
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Pobbati, A. V., & Hong, W. (2020) · Theranostics · doi:10.7150/thno.40889 · Cited by 223 · see citing works
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213 · see citing works
Li, Q., Sun, Y., Jarugumilli, G. K., Liu, S., Dang, K., Cotton, J. L., Xiol, J., Chan, P. Y., DeRan, M., Ma, L., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.03.002 · Cited by 180 · see citing works
Self-citationThe role of YAP/TAZ activity in cancer metabolic reprogramming
Zhang, X., Zhao, H., Li, Y., Xia, D., Yang, L., Ma, Y., & Li, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0882-1 · Cited by 210 · see citing works
Bum‐Erdene, K., Zhou, D., González-Gutiérrez, G., Ghozayel, M. K., Si, Y., Xu, D. D., Shannon, H. E., Bailey, B. J., Corson, T. W., Pollok, K. E., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.11.010 · Cited by 200 · see citing works
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park, J. H., Shin, J. E., & Park, H. W. (2018) · PubMed Central · doi:10.14348/molcells.2018.2242 · Cited by 195 · see citing works
Integration of Hippo-YAP Signaling with Metabolism
Ibar, C., & Irvine, K. D. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.025 · Cited by 189 · see citing works
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
Xu, H., Zhao, H., Ding, C., Jiang, D., Zhao, Z., Li, Y., Ding, X., Gao, J., Zhou, H., Luo, C., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01231-4 · Cited by 190 · see citing works
Metabolites Regulate Cell Signaling and Growth via Covalent Modification of Proteins
Figlia, G., Willnow, P., & Teleman, A. A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.036 · Cited by 184 · see citing works
Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
Holden, J. K., & Cunningham, C. N. (2018) · Cancers · doi:10.3390/cancers10030081 · Cited by 175 · see citing works
Holden, J. K., Crawford, J. J., Noland, C. L., Schmidt, S., Zbieg, J. R., Lacap, J. A., Zang, R., Miller, G. M., Zhang, Y., Beroza, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107809 · Cited by 166 · see citing works
Control of stem cell renewal and fate by YAP and TAZ
Driskill, J. H., & Pan, D. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00644-5 · Cited by 165 · see citing works
Self-citationTherapeutic targeting of TEAD transcription factors in cancer
Pobbati, A. V., Kumar, R., Rubin, B. P., & Hong, W. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.12.005 · Cited by 147 · see citing works
Dynamic Protein Acylation: New Substrates, Mechanisms, and Drug Targets
Lanyon‐Hogg, T., Faronato, M., Serwa, R. A., & Tate, E. W. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.04.004 · Cited by 146 · see citing works
Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells
Sun, Y., Hu, L., Tao, Z., Jarugumilli, G. K., Erb, H., Singh, A., Li, Q., Cotton, J. L., Greninger, P., Egan, R. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34559-0 · Cited by 145 · see citing works
Self-citationKaneda, A., Seike, T., Danjo, T., Nakajima, T., Otsubo, N., Yamaguchi, D., Tsuji, Y., Hamaguchi, K., Yasunaga, M., Nishiya, Y., et al. (2020) · PubMed Central · Cited by 139 · see citing works
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5
Cao, Y., Qiu, T., Kathayat, R. S., Azizi, S., Thorne, A. K., Ahn, D. J., Fukata, Y., Fukata, M., Rice, P. A., & Dickinson, B. C. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0399-y · Cited by 134 · see citing works
A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications
Suazo, K. F., Park, K., & Distefano, M. D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01108 · Cited by 119 · see citing works
TEAD family transcription factors in development and disease
Currey, L., Thor, S., & Piper, M. (2021) · Development · doi:10.1242/dev.196675 · Cited by 120 · see citing works
ZDHHC7-mediated S-palmitoylation of Scribble regulates cell polarity
Chen, B., Zheng, B., DeRan, M., Jarugumilli, G. K., Fu, J., Brooks, Y. S., & Wu, X. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2119 · Cited by 119 · see citing works
Self-citationYap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Cox, A. G., Tsomides, A., Yimlamai, D., Hwang, K. L., Miesfeld, J. B., Galli, G. G., Fowl, B. H., Fort, M. W., Kimberly, Y., Sullivan, M. R., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100294 · Cited by 116 · see citing works
Protein Palmitoylation and Its Role in Bacterial and Viral Infections
Sobocińska, J., Roszczenko, P., Ciesielska, A., & Kwiatkowska, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02003 · Cited by 117 · see citing works
Kaan, H. Y. K., Chan, S. W., Tan, S. K. J., Guo, F., Lim, C. J., Hong, W., & Song, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-02219-9 · Cited by 111 · see citing works
Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes
Kathayat, R. S., Cao, Y., Elvira, P. D., Sandoz, P. A., Zaballa, M.-E., Springer, M. Z., Drake, L. E., Macleod, K. F., van der Goot, F. G., & Dickinson, B. C. (2018) · Nature Communications · doi:10.1038/s41467-017-02655-1 · Cited by 109 · see citing works
The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics
Zaballa, M.-E., & van der Goot, F. G. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1488804 · Cited by 105 · see citing works
Lipid-induced S-palmitoylation as a Vital Regulator of Cell Signaling and Disease Development
Qu, M., Zhou, X., Wang, X., & Li, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64046 · Cited by 110 · see citing works
GPCR-Hippo Signaling in Cancer
Luo, J., & Yu, F. (2019) · Cells · doi:10.3390/cells8050426 · Cited by 104 · see citing works
Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery
Li, Q., & Kang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155262 · Cited by 103 · see citing works
Targeting Transcriptional Enhanced Associate Domains (TEADs)
Gibault, F., Sturbaut, M., Bailly, F., Melnyk, P., & Cotelle, P. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00879 · Cited by 102 · see citing works
Mediated nuclear import and export of TAZ and the underlying molecular requirements
Kofler, M., Speight, P., Little, D., Ciano‐Oliveira, C. D., Szászi, K., & Kapùs, A. (2018) · Nature Communications · doi:10.1038/s41467-018-07450-0 · Cited by 102 · see citing works
The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
Rognoni, E., & Walko, G. (2019) · Cells · doi:10.3390/cells8050411 · Cited by 99 · see citing works
A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations
Yamaguchi, H., & Taouk, G. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00928 · Cited by 100 · see citing works
Liu, Y., Zhang, H., Liu, Y., Zhang, S., Su, P., Wang, L., Li, Y., Liang, Y., Wang, X., Zhao, W., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2182482 · Cited by 100 · see citing works
Lu, W., Wang, J., Li, Y., Tao, H., Xiong, H., Lian, F., Gao, J., Ma, H., Lu, T., Zhang, D., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111767 · Cited by 94 · see citing works
Talukdar, P. D., & Chatterji, U. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01651-w · Cited by 96 · see citing works
Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer
Baroja, I., Kyriakidis, N. C., Halder, G. A., & Moya, I. M. (2024) · Nature Communications · doi:10.1038/s41467-024-46531-1 · Cited by 92 · see citing works
A Decade of Click Chemistry in Protein Palmitoylation: Impact on Discovery and New Biology
Gao, X., & Hannoush, R. N. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.12.002 · Cited by 91 · see citing works
Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity
Kim, N., & Gumbiner, B. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819400116 · Cited by 91 · see citing works
Jeong, D., Park, J., Kim, K.-S., Kim, J., Huh, J., Seo, J., Kim, Y., Cho, J., Lee, K., Fukuda, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42170-0 · Cited by 91 · see citing works
Osman, I., He, X., Liu, J., Dong, K., Wen, T., Zhang, F., Yu, L., Hu, G., Xin, H., Zhang, W., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314187 · Cited by 89 · see citing works
Mokhtari, R. B., Ashayeri, N., Baghaie, L., Sambi, M., Satari, K., Baluch, N., Bosykh, D. A., Szewczuk, M. R., & Chakraborty, S. (2023) · Cancers · doi:10.3390/cancers15133468 · Cited by 88 · see citing works
Hippo pathway inhibition by blocking the YAP/TAZ–TEAD interface: a patent review
Crawford, J. J., Bronner, S. M., & Zbieg, J. R. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1549226 · Cited by 86 · see citing works
Structure and function of DHHC protein S-acyltransferases
Gottlieb, C. D., & Linder, M. E. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160304 · Cited by 85 · see citing works
Structure and Mechanism of DHHC Protein Acyltransferases
Stix, R., Lee, C., Faraldo‐Gómez, J. D., & Banerjee, A. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.05.023 · Cited by 84 · see citing works
Aflatoxin Biosynthesis, Genetic Regulation, Toxicity, and Control Strategies: A Review
Khan, R., Ghazali, F. M., Mahyudin, N. A., & Samsudin, N. I. P. (2021) · Journal of Fungi · doi:10.3390/jof7080606 · Cited by 83 · see citing works
Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
Pellerin, L., Carrié, L., Dufau, C., Nieto, L., Ségui, B., Levade, T., Riond, J., & Andrieu‐Abadie, N. (2020) · Cancers · doi:10.3390/cancers12113147 · Cited by 82 · see citing works
New insights into the ambivalent role of YAP/TAZ in human cancers
Luo, J., Deng, L., Zou, H., Guo, Y., Tong, T., Huang, M., Ling, G., & Li, P. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02704-2 · Cited by 83 · see citing works
A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling
Kathayat, R. S., Elvira, P. D., & Dickinson, B. C. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2262 · Cited by 81 · see citing works
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
Yap, T. A., Kwiatkowski, D. J., Dagogo‐Jack, I., Offin, M. D., Zauderer, M. G., Kratzke, R. A., Desai, J., Body, A. L., Millward, M., Tolcher, A. W., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-04029-3 · Cited by 81 · see citing works
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 76 · see citing works
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead MSC-4106
Heinrich, T., Peterson, C., Schneider, R., Garg, S., Schwarz, D. F., Gunera, J., Seshire, A., Kötzner, L., Schlesiger, S., Müsil, D., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00403 · Cited by 76 · see citing works
Diverse Roles of Protein Palmitoylation in Cancer Progression, Immunity, Stemness, and Beyond
Li, M., Zhang, L., & Chen, C.-W. D. (2023) · Cells · doi:10.3390/cells12182209 · Cited by 73 · see citing works
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
Espinosa-Sánchez, A., Suárez-Martínez, E., Sánchez-Díaz, L., & Carnero, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01533 · Cited by 71 · see citing works
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Barry, E., Simov, V., Valtingojer, I., & Venier, O. (2021) · Cells · doi:10.3390/cells10102715 · Cited by 71 · see citing works
Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ
Mesrouze, Y., Meyerhofer, M., Bokhovchuk, F. M., Fontana, P., Zimmermann, C., Martin, T., Delaunay, C., Izaac, A., Kallen, J. A., Schmelzle, T., et al. (2017) · Protein Science · doi:10.1002/pro.3312 · Cited by 70 · see citing works
DNA-binding mechanism of the Hippo pathway transcription factor TEAD4
Shi, Z., He, F., Chen, M., Hua, L., Wang, W., Jiao, S., & Zhou, Z. (2017) · Oncogene · doi:10.1038/onc.2017.24 · Cited by 69 · see citing works
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
Fan, M., Lu, W., Che, J., Kwiatkowski, N. P., Gao, Y., Seo, H.-S., Ficarro, S. B., Gokhale, P. C., Liu, Y., Geffken, E. A., et al. (2022) · eLife · doi:10.7554/elife.78810 · Cited by 68 · see citing works
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling
Coggins, G. E., Farrel, A., Rathi, K. S., Hayes, C. M., Scolaro, L., Rokita, J. L., & Maris, J. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1415 · Cited by 66 · see citing works
Karataş, H., Akbarzadeh, M., Adihou, H., Hahne, G., Pobbati, A. V., Ng, E. Y., Guéret, S. M., Sievers, S., Pahl, A., Metz, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01275 · Cited by 66 · see citing works
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
Luo, J., Zou, H., Guo, Y., Tong, T., Chen, Y., Xiao, Y., Pan, Y., & Li, P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02182-5 · Cited by 66 · see citing works
Targeting the Hippo pathway in cancer
Harvey, K. F., & Tang, T. T.-L. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01234-0 · Cited by 65 · see citing works
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
Tate, E. W., Soday, L., de la Lastra, A. L., Wang, M., & Lin, H. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00666-x · Cited by 61 · see citing works
Mesrouze, Y., Bokhovchuk, F. M., Meyerhofer, M., Fontana, P., Zimmermann, C., Martin, T., Delaunay, C., Erdmann, D., Schmelzle, T., & Chêne, P. (2017) · eLife · doi:10.7554/elife.25068 · Cited by 59 · see citing works
Yu, Y., Su, X., Qin, Q., Hou, Y., Zhang, X., Zhang, H., Jia, M., & Chen, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105009 · Cited by 59 · see citing works
Vaidyanathan, S., Salmi, T. M., Sathiqu, R. M., McConville, M. J., Cox, A. G., & Brown, K. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.004 · Cited by 56 · see citing works
Structural and Functional Overview of TEAD4 in Cancer Biology
Chen, M., Huang, B., Zhu, L., Chen, K., Liu, M., & Zhong, C. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s266649 · Cited by 54 · see citing works
Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors
Lu, W., Fan, M., Ji, W., Tse, J., You, I., Ficarro, S. B., Tavares, I., Che, J., Kim, A. Y., Zhu, X., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01548 · Cited by 52 · see citing works
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
Pobbati, A. V., & Rubin, B. P. (2020) · Molecules · doi:10.3390/molecules25246001 · Cited by 52 · see citing works
Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
Zagiel, B., Melnyk, P., & Cotelle, P. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2096436 · Cited by 51 · see citing works
Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer
Kiang, K. M. Y., Ahad, L., Zhong, X., & Lu, Q. R. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.04.009 · Cited by 54 · see citing works
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
Lu, T., Li, Y., Lu, W., Spitters, T., Fang, X., Wang, J., Cai, S., Gao, J., Zhou, Y., Duan, Z., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.015 · Cited by 50 · see citing works
Identification of Quinolinols as Activators of TEAD-Dependent Transcription
Pobbati, A. V., Mejuch, T., Chakraborty, S., Karataş, H., Bharath, S. R., Guéret, S. M., Goy, P.-A. V., Hahne, G., Pahl, A., Sievers, S., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00786 · Cited by 49 · see citing works
Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
Lv, L., & Zhou, X. (2023) · MedComm · doi:10.1002/mco2.375 · Cited by 47 · see citing works
Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
Kumar, R., & Hong, W. (2024) · Cells · doi:10.3390/cells13070564 · Cited by 47 · see citing works
Wu, L., Yang, Y., Li, B., Huang, W., Wang, X., Liu, X., Meng, Z., & Xia, J. (2019) · Marine Biotechnology · doi:10.1007/s10126-019-09916-8 · Cited by 47 · see citing works
Gadalla, M. R., & Veit, M. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1696306 · Cited by 44 · see citing works
Hu, L., Sun, Y., Liu, S., Erb, H., Singh, A., Mao, J., Luo, X., & Wu, X. (2022) · eLife · doi:10.7554/elife.80210 · Cited by 48 · see citing works
Self-citationThe Hippo pathway: Organ size control and beyond
Guo, P., Wan, S., & Guan, K. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100031 · Cited by 45 · see citing works
Repurposing of Drugs Targeting YAP-TEAD Functions
Elisi, G. M., Santucci, M., D’Arca, D., Lauriola, A., Marverti, G., Losi, L., Scalvini, L., Bolognesi, M. L., Mor, M., & Costi, M. P. (2018) · Cancers · doi:10.3390/cancers10090329 · Cited by 46 · see citing works
Kim, H., & Nam, J. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01551-9 · Cited by 51 · see citing works
- Authors
- Chan, P., Han, X., Zheng, B., DeRan, M., Yu, J., Jarugumilli, G. K., Deng, H., Pan, D., Luo, X., & Wu, X.
- Affiliations
- Harvard University (US)
- Jilin University (CN)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Luo, Xuelian
- Wu, Xu
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2016-02-22
- Volume
- 12
- Issue
- 4
- Pages
- 282-289
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC4798901
- OpenAlex
- W2274646531
- Cited by
- 313
- References
- 49
- Citations by year
- 2026: 40 · 2025: 38 · 2024: 54 · 2023: 37 · 2022: 39 · 2021: 21 · 2020: 26 · 2019: 19 · 2018: 21 · 2017: 13 · 2016: 4
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense (DE-AC02-06CH11357, R01CA181537, W81XWH, R01DK107651, W81XWH-13)
- Howard Hughes Medical Institute
- U.S. Department of Energy (DE‐ AC02‐06CH11357, AC02‐06CH11357, 06CH11357, DE-AC02-)
- Melanoma Research Alliance (R01CA181537, R01DK107651)
- University of Texas Southwestern Medical Center
- National Institutes of Health (DE-AC02–06CH11357, W81XWH)
- National Eye Institute (R01EY015708)
- National Cancer Institute (R01CA181537, DE-AC02-06CH11357)
- National Institute of General Medical Sciences (DE-AC02-06CH11357, R01GM107415)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107651)
- Argonne National Laboratory (DE- AC02-06-CH11357, DE-AC02, AC02–06CH11357, 06CH11357)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- TEAD transcription factors, S-palmitoylation, Hippo signaling pathway, YAP, TAZ, VGLL4, protein lipidation, transcriptional regulation, myogenesis, tissue overgrowth, Yorkie, organ size control
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, TEA Domain Transcription Factors, Amino Acid Sequence, Animals, Cell Differentiation, Cell Line, Cysteine, DNA-Binding Proteins, Fatty Acids, Unsaturated, Humans, Models, Molecular, Molecular Sequence Data, Nuclear Proteins, Palmitates, Protein Binding, Transcription Factors, Signal Transduction, Trans-Activators, Sequence Alignment, Conserved Sequence, Protein Serine-Threonine Kinases, Muscle Fibers, Skeletal, Protein Transport, Drosophila Proteins, Lipoylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
